Previous Page  6 / 18 Next Page
Information
Show Menu
Previous Page 6 / 18 Next Page
Page Background

Page 23

Notes:

J Obes Eat Disord, 2017

ISSN: 2471-8203

August 23-24, 2017 | Toronto, Canada

allied

academies

INTERNATIONAL OBESITY, BARIATRIC AND

METABOLIC SURGERY SUMMIT AND EXPO

César Antonio Martínez-Ortiz, J Obes Eat Disord, 3:2

DOI: 10.21767/2471-8203-C1-002

Introduction:

Diabetes is common in obese patients in

Mexico. Risk factors affecting the distribution and frequency

of type 2 diabetes mellitus (T2DM) and their complications

are well known. It is often associated with overweight or

obesity, which in turn can cause insulin resistance and

elevated blood glucose levels.

Objective:

The objective of the study is to determine if there

is remission of T2DM in patients undergoing vertical sleeve

gastrectomy (VSG) or Roux-en-Y gastric bypass (RYGB) and, if

so, after which one is greater.

Methods:

Descriptive, observational, longitudinal and

retrospective analysis of data from 33 patients with T2DM

and obesity who underwent vertical sleeve gastrectomy or

Roux-en-Y gastric bypass, preoperatively and at 12-month

follow-up was done. Diabetes remission was defined as

glucose below the diagnostic thresholds for T2DM (HbA1c <

6%, fasting glucose < 100 mg/dl if HbA1c was not available)

and abscense of active hypoglycemic medication.

Results:

Thirty-three patients with diagnosis of obesity and

T2DM were divided into two groups: 8 patients, 1 man (3.03

%) and 7 women (21.21 %), VSG; and 25 patients, 6 men

(18.18 %) and 19 women (57.50 %), RYGB. After 1 year of

follow-up, there was remission in 7 (21.21 %) of 8 patients in

the VSG group and in 24 (72.72 %) in 25 (93.93 %) patients

in the RYGB group.

Conclusion:

Bariatric/metabolic surgery can reverse or

improve T2DM in obese patients, and is more effective than

medical interventions and lifestyle modifications for weight

loss, glycemic control, remission of T2DM, improvements

in other cardiovascular risk factors and the decrease of

cardiovascular diseases.

Speaker Biography

César Antonio Martínez-Ortiz attended the MD program at National Autonomous

University of Mexico School of Medicine, and both the General Surgery Residency

Program and Bariatric/Metabolic Surgery Fellowship at the National Medical Center

of the Mexican Social Security Institute, where he is currently Senior Surgeon and

Professor both in the Department of Surgery and in the Obesity and Metabolic

Diseases Clinic. He also obtained the Master’s degree in Health Directive Management

at the University of the Valley of Mexico, Laureate International Universities. He is a

young Surgeon, interested in clinical and surgical practice, education and research, and

hopes to stand out internationally.

e:

camartinez@me.com

Evolution of type 2 diabetes mellitus in patients undergoing vertical sleeve gastrectomy or Roux-en-Y

gastric bypass

César Antonio Martínez-Ortiz

Mexican Social Security Institute, Mexico

National Autonomous University of Mexico School of Medicine, Mexico